Statement Of Financial Position [Abstract]

RaySearch Laboratories - Filing #688578

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Right-of-use assets	540 209 SEK	—	—	—	—	—	—	—	540 188 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax assets	25 598 SEK	—	—	—	—	—	—	—	28 525 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	160 268 SEK	—	—	—	—	—	—	—	102 535 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	168 746 SEK	—	—
Assets	1 875 950 SEK	—	—	—	—	—	—	—	1 744 746 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	17 141 SEK	—	—	—	—	—	—	—	17 141 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	640 410 SEK	—	—	—	—	—	—	—	616 632 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	657 156 SEK	—	—	—	—	—	—	—	628 312 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	657 156 SEK	640 410 SEK	17 141 SEK	2 370 SEK	657 156 SEK	1 975 SEK	616 632 SEK	1 975 SEK	628 312 SEK	628 312 SEK	7 436 SEK	17 141 SEK	663 947 SEK	684 913 SEK	20 966 SEK	1 975 SEK	673 385 SEK	17 141 SEK	17 141 SEK	20 966 SEK	694 351 SEK	9 678 SEK	—	1 975 SEK	9 678 SEK
Liabilities [abstract]
Deferred tax liabilities	106 874 SEK	—	—	—	—	—	—	—	107 784 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Liabilities	1 218 794 SEK	—	—	—	—	—	—	—	1 116 434 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	1 875 950 SEK	—	—	—	—	—	—	—	1 744 746 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—